Royal Bank of Canada
AMPE

Royal Bank of Canada’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Royal Bank of Canada’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2
Closed – – 7891
2023
Q4 		$0 Buy
+2
New +$5 ﹤0.01% 7915
2022
Q3 		– Sell
-2
Closed – – 8199
2022
Q2 		$0 Sell
2
-48
-96% -$3.57K ﹤0.01% 8143
2022
Q1 		$7K Sell
50
-114
-70% -$16.6K ﹤0.01% 7161
2021
Q4 		$28K Buy
164
+77
+89% +$28.7K ﹤0.01% 6653
2021
Q3 		$43K Buy
87
+33
+61% +$15.3K ﹤0.01% 6254
2021
Q2 		$27K Buy
54
+37
+218% +$19.9K ﹤0.01% 6408
2021
Q1 		$8K Buy
17
+7
+70% +$3.61K ﹤0.01% 6917
2020
Q4 		$5K Sell
10
-32
-76% -$10.5K ﹤0.01% 6690
2020
Q3 		$12K Hold
42
– – ﹤0.01% 5883
2020
Q2 		$8K Buy
42
+37
+740% +$6.15K ﹤0.01% 5930
2020
Q1 		$1K Sell
5
-2
-29% -$362 ﹤0.01% 6554
2019
Q4 		$1K Hold
7
– – ﹤0.01% 6732
2019
Q3 		$1K Hold
7
– – ﹤0.01% 6574
2019
Q2 		$1K Hold
7
– – ﹤0.01% 6774
2019
Q1 		$1K Sell
7
-1
-13% -$171 ﹤0.01% 6708
2018
Q4 		$1K Sell
8
-6
-43% -$921 ﹤0.01% 6637
2018
Q3 		$2K Buy
14
+12
+600% +$5.02K ﹤0.01% 6548
2018
Q2 		$1K Hold
2
– – ﹤0.01% 6422
2018
Q1 		$2K Hold
2
– – ﹤0.01% 6145
2017
Q4 		$2K Buy
2
+1
+100% +$470 ﹤0.01% 6320
2017
Q3 		$0 Sell
1
-3
-75% -$475 ﹤0.01% 7098
2017
Q2 		$1K Sell
4
-4
-50% -$809 ﹤0.01% 6463
2017
Q1 		$2K Sell
8
-1
-11% -$269 ﹤0.01% 6452
2016
Q4 		$3K Buy
9
+6
+200% +$1.43K ﹤0.01% 6431
2016
Q3 		$1K Hold
3
– – ﹤0.01% 6330
2016
Q2 		$1K Hold
3
– – ﹤0.01% 6289
2016
Q1 		$2K Hold
3
– – ﹤0.01% 6155
2015
Q4 		$4K Hold
3
– – ﹤0.01% 6240
2015
Q3 		$3K Hold
3
– – ﹤0.01% 6324
2015
Q2 		$2K Sell
3
-4
-57% -$4.26K ﹤0.01% 6389
2015
Q1 		$15K Hold
7
– – ﹤0.01% 5448
2014
Q4 		$7K Sell
7
-41
-85% -$43.8K ﹤0.01% 5726
2014
Q3 		$51K Sell
48
-4
-8% -$6.74K ﹤0.01% 4944
2014
Q2 		$129K Buy
52
+4
+8% +$8.16K ﹤0.01% 4418
2014
Q1 		$92K Sell
48
-5
-9% -$11.8K ﹤0.01% 4587
2013
Q4 		$113K Sell
53
-16
-23% -$37.8K ﹤0.01% 4507
2013
Q3 		$154K Buy
69
+1
+1% +$1.93K ﹤0.01% 4241
2013
Q2 		$118K Buy
+68
New +$108K ﹤0.01% 4215

Other funds holding AMPE

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada's AMPE Position: Q1 2024 in Review

Royal Bank of Canada sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2024, closing a stake of 2 shares.

Royal Bank of Canada first reported a position in AMPE in Q2 2013 and held it in 38 quarters. The position peaked at $154K in Q3 2013. 28 funds tracked by Wall St. Rank hold AMPE as of Q1 2024.

  • Royal Bank of Canada reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 2 Ampio Pharmaceuticals Inc. shares in Q1 2024.
  • Royal Bank of Canada first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 38 quarters.
  • Royal Bank of Canada's Ampio Pharmaceuticals Inc. position peaked at $154K in Q3 2013.
  • 28 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2024.

Based on Royal Bank of Canada's 13F filing for Q1 2024, filed 15 May 2024.